Panacea Biotec launches Tetravalent Vaccine Easyfour-TT

For protection of infants from DTP and Hib

Panacea Biotec announced the launch of Tetravalent Vaccine Easyfour-TT for active primary immunization and booster dose against diphtheria, tetanus and pertussis (DTP) and Haemophilus Influenza Type B(Hib).

Easyfour-TT, world's first fully liquid Tetravalent vaccine launched in India, will protect infant from Diptheria, Tetanus, Whopping Cough and Hib-Meningitis.

Powered by Capital Market - Live News